| pubmed-article:19218272 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19218272 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:19218272 | lifeskim:mentions | umls-concept:C0024400 | lld:lifeskim |
| pubmed-article:19218272 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:19218272 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:19218272 | lifeskim:mentions | umls-concept:C0599896 | lld:lifeskim |
| pubmed-article:19218272 | lifeskim:mentions | umls-concept:C0388088 | lld:lifeskim |
| pubmed-article:19218272 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:19218272 | pubmed:dateCreated | 2009-3-12 | lld:pubmed |
| pubmed-article:19218272 | pubmed:abstractText | FTY720 causes retention of lymphocytes in lymphatic tissues. Previous studies revealed that FTY720 can decrease or eliminate chronic viral infections of mice. We address here whether therapeutic use of FTY720 in simian human immunodeficiency virus (SHIV)-infected rhesus macaques could also decrease viraemia. | lld:pubmed |
| pubmed-article:19218272 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19218272 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19218272 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19218272 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19218272 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19218272 | pubmed:issn | 1460-2091 | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:LuoWeiW | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:MitchellJames... | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:KershEllen... | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:AdamsDebra... | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:ButeraSalS | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:Garcia-LermaJ... | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:FolksTomT | lld:pubmed |
| pubmed-article:19218272 | pubmed:author | pubmed-author:OttenRonR | lld:pubmed |
| pubmed-article:19218272 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19218272 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:19218272 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19218272 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19218272 | pubmed:pagination | 758-62 | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:meshHeading | pubmed-meshheading:19218272... | lld:pubmed |
| pubmed-article:19218272 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19218272 | pubmed:articleTitle | Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques. | lld:pubmed |
| pubmed-article:19218272 | pubmed:affiliation | Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. ekersh@cdc.gov | lld:pubmed |
| pubmed-article:19218272 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19218272 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
